Drugs / GW685698
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00731822 | Aug 2008 → Feb 2009 | chronic obstructive pulmonary disease | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00358475 | Jun → Oct 2005 | seasonal allergic rhinitis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GW685698 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00731822 ↗ |
| Route | Intranasal | “investigational nasal spray” NCT00358475 ↗ |